🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "specific steps to address household expense issues" in the forthcoming financial statement.

During an interview with media outlets, she stated that lowering price rises is a joint task of both the government and the central bank.

The United Kingdom's price growth is forecast to be the highest among the Group of Seven advanced economies this calendar year and the following year.

Potential Utility Bill Measures

It is understood the administration could take action to lower utility costs, for example by cutting the present 5% level of value-added tax charged on energy.

An additional option is to lower some of the policy costs presently included in bills.

Budgetary Constraints and Expert Predictions

The government will receive the latest draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much space there is for these actions.

The consensus from most economists is that Reeves will have to announce tax rises or expenditure reductions in order to adhere to her self-imposed fiscal targets.

Previously on Thursday, calculations suggested there was a £22bn shortfall for the Treasury chief to fill, which is at the more modest range of projections.

"It is a shared task between the central bank and the administration to further reduce some of the causes of inflation," Reeves told the BBC in Washington, at the annual meetings of the IMF and World Bank.

Revenue Commitments and International Issues

While a great deal of the focus has been on probable tax increases, the chancellor said the most recent data from the fiscal watchdog had not altered her commitment to campaign commitments not to raise tax levels on earnings tax, sales tax or National Insurance.

She attributed an "uncertain global environment" with rising international and trade concerns for the Budget tax moves, probably to be focused on those "wealthiest."

Global Economic Tensions

Commenting on worries about the UK's trade ties with the Asian nation she said: "Our national security always are paramount."

Recent declaration by Chinese authorities to increase export controls on rare earths and other materials that are essential for advanced tech production led American leader the US President to propose an extra 100% tariff on goods from the Asian country, raising the risk of an all-out commercial conflict between the two largest economies.

The American finance chief called China's action "commercial pressure" and "a global supply chain power grab."

Inquired about considering the US offer to participate in its dispute with China, the Chancellor said she was "extremely troubled" by China's measures and urged the Beijing authorities "not to put up barriers and restrict access."

She said the action was "damaging for the international commerce and generates further headwinds."

"I believe there are sectors where we must address Chinese policies, but there are also important prospects to export to China's economy, including financial services and other areas of the economy. We've got to get that equilibrium right."

The chancellor also affirmed she was cooperating with other major economies "regarding our own essential resources approach, so that we are reduced dependence."

NHS Drug Pricing and Funding

The Chancellor also acknowledged that the cost the National Health Service pays for drugs could increase as a consequence of current talks with the Trump administration and its pharmaceutical firms, in return for lower tariffs and capital.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either pausing or canceling projects in the UK, with some blaming the insufficient payments they are obtaining.

Last month, the Science Minister said the cost the health service pays for medicines would have to increase to prevent businesses and drug research funding leaving the United Kingdom.

The Chancellor informed the BBC: "It has been observed due to the cost structure, that medical research, new drugs have not been provided in the United Kingdom in the way that they are in other European countries."

"We want to ensure that people receiving treatment from the NHS are can obtain the finest essential medicines in the world. And so we are reviewing all of that, and... seeking to attract more funding into Britain."